Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cytokinetics Inc. buy Truist Financial Co.

Start price
€45.00
29.05.24 / 50%
Target price
€64.57
29.05.25
Performance (%)
-40.00%
End price
€27.00
30.05.25
Summary
This prediction ended on 30.05.25 with a price of €27.00. The BUY prediction by Truist_Financial_Co_ for Cytokinetics Inc. performed very badly with a performance of -40.00%. Truist_Financial_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Cytokinetics Inc. -1.923% -1.923% 11.842%
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

Comments by Truist_Financial_Co_ for this prediction

In the thread Discuss Cytokinetics Inc.
Prediction Buy
Perf. (%) -40.00%
Target price 64.568
Change
Ends at 29.05.25

Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Truist Financial Co. from $86.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat

In the thread Trading Cytokinetics Inc.
Prediction Buy
Perf. (%) -40.00%
Target price 64.568
Change
Ends at 29.05.25

Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Truist_Financial_Co_ for Cytokinetics Inc.

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€68.00
08.04.24
€79.21
08.04.25
-53.24%
09.04.25

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€76.00
28.12.23
€77.64
28.12.24
-41.05%
29.12.24